Blog

The Petri Dish: Pfizer signs licensing deal with oncology startup, Ikena sets IPO terms

the-petri-dish-logo900xx3315-2216-13-0

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here’s The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.

Read More